Total Payments
$7,635
2023 Payments
$523.02
Companies
46
Transactions
446
Medicare Patients
1,388
Medicare Billing
$339,303
Payment Breakdown by Category
Food & Beverage$7,635 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,635 | 446 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $1,054 | 56 | $0 (2023) |
| Novo Nordisk Inc | $837.88 | 54 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $822.81 | 46 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $653.62 | 40 | $0 (2022) |
| PFIZER INC. | $553.61 | 32 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $541.61 | 38 | $0 (2023) |
| Allergan, Inc. | $373.11 | 34 | $0 (2020) |
| PREVENTRIC DIAGNOSTICS, INC. | $260.20 | 2 | $0 (2022) |
| Lilly USA, LLC | $260.02 | 17 | $0 (2022) |
| Amgen Inc. | $252.74 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $523.02 | 26 | AbbVie Inc. ($214.07) |
| 2022 | $1,811 | 94 | ABBVIE INC. ($427.59) |
| 2021 | $1,821 | 106 | AbbVie Inc. ($412.03) |
| 2020 | $1,003 | 68 | Allergan, Inc. ($205.62) |
| 2019 | $1,364 | 84 | AstraZeneca Pharmaceuticals LP ($315.61) |
| 2018 | $568.66 | 33 | AstraZeneca Pharmaceuticals LP ($243.27) |
| 2017 | $544.15 | 35 | Takeda Pharmaceuticals America, Inc. ($128.39) |
All Payment Transactions
446 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: PAIN | ||||||
| 04/11/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Diabetes | ||||||
| 03/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: PAIN | ||||||
| 02/13/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Cardiovascular | ||||||
| 02/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Diabetes | ||||||
| 02/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Inflammation | ||||||
| 01/25/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/24/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: ADHD | ||||||
| 01/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/10/2023 | Noven Therapeutics, LLC | Secuado (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: CNS Psychiatry | ||||||
| 01/04/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Diabetes | ||||||
| 01/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 296 | 1,082 | $205,475 | $81,114 |
| 2022 | 9 | 365 | 1,296 | $219,960 | $94,117 |
| 2021 | 12 | 423 | 1,368 | $227,375 | $96,927 |
| 2020 | 8 | 304 | 1,155 | $173,815 | $67,145 |
Total Patients
1,388
Total Services
4,901
Medicare Billing
$339,303
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 548 | $95,900 | $39,911 | 41.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 55 | 224 | $38,175 | $12,723 | 33.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 29 | 149 | $36,125 | $10,839 | 30.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 19 | 74 | $13,975 | $7,381 | 52.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 44 | $9,900 | $3,980 | 40.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 23 | 23 | $6,900 | $3,540 | 51.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $4,500 | $2,739 | 60.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 632 | $110,600 | $45,073 | 40.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 45 | 246 | $36,900 | $14,360 | 38.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 14 | 175 | $30,625 | $13,024 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 104 | $23,400 | $10,441 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 65 | 65 | $14,625 | $9,091 | 62.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,400 | $959.56 | 68.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 15 | 15 | $1,350 | $612.45 | 45.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $480.00 | $470.40 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 20 | 29 | $580.00 | $85.89 | 14.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 118 | 675 | $118,125 | $47,691 | 40.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 41 | 246 | $36,900 | $14,106 | 38.2% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 14 | 154 | $26,950 | $11,332 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 70 | 70 | $15,750 | $9,874 | 62.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 76 | $17,100 | $7,736 | 45.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 14 | 14 | $4,200 | $2,191 | 52.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 22 | 23 | $2,300 | $1,492 | 64.9% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 26 | 26 | $1,950 | $1,092 | 56.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 14 | $1,540 | $631.82 | 41.0% |
About Dr. Daniel Rosenthal, MD
Dr. Daniel Rosenthal, MD is a Psychiatry healthcare provider based in Skokie, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023120599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Rosenthal, MD has received a total of $7,635 in payments from pharmaceutical and medical device companies, with $523.02 received in 2023. These payments were reported across 446 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($7,635).
As a Medicare-enrolled provider, Rosenthal has provided services to 1,388 Medicare beneficiaries, totaling 4,901 services with total Medicare billing of $339,303. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Internal Medicine
- Location Skokie, IL
- Active Since 08/31/2006
- Last Updated 12/07/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023120599
Products in Payments
- VRAYLAR (Drug) $1,264
- XARELTO (Drug) $539.52
- FARXIGA (Drug) $444.42
- Ozempic (Drug) $408.86
- CHANTIX (Drug) $352.32
- SYMBICORT (Drug) $306.34
- TRINTELLIX (Drug) $264.16
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $260.20
- Trintellix (Drug) $254.23
- Rybelsus (Drug) $240.89
- JARDIANCE (Drug) $192.27
- AUSTEDO (Drug) $157.50
- ENTRESTO (Drug) $147.40
- VYVANSE (Drug) $137.32
- NURTEC ODT (Drug) $128.77
- ELIQUIS (Drug) $114.44
- REXULTI (Drug) $94.75
- NEXLETOL (Drug) $93.97
- SPRAVATO (Drug) $89.92
- MOUNJARO (Drug) $89.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Skokie
Dr. Mark Shukhman, Md, MD
Psychiatry — Payments: $257,169
Psychiatry $257,169
John Zajecka, M.d, M.D
Psychiatry — Payments: $117,989
Psychiatry $117,989
Dr. Kathleen Johnson, M.d, M.D
Psychiatry — Payments: $6,911
Psychiatry $6,911
Joshua Eloge, Md, MD
Psychiatry — Payments: $6,504
Psychiatry $6,504
Dr. Heidi Meredith, Md, MD
Psychiatry — Payments: $5,862
Psychiatry $5,862
Adrienne Balsam, Md, MD
Psychiatry — Payments: $4,312
Psychiatry $4,312